VeriMomsalicyloyl pentapeptide-33 hamilelikte güvenli mi?
No harmonised CLP classification (ECHA Annex VI), no SCCS or CIR safety assessment specific to salicyloyl pentapeptide‑33, and no peer‑reviewed reproductive toxicity data located. As a large peptide conjugate with no specific evidence of systemic reproductive toxicity, default hazard/mechanism scores are 0. The salicyloyl moiety raises a theoretical consideration (salicylates can have systemic effects at high exposure), but no data indicate that topical use of this peptide leads to relevant maternal exposure (sources checked: ECHA Annex VI, SCCS/CIR repositories, PubMed, PubChem, CosIng, EWG).
Related ingredients
Frequently asked questions
- salicyloyl pentapeptide-33 hamilelikte güvenli mi?
- No harmonised CLP classification (ECHA Annex VI), no SCCS or CIR safety assessment specific to salicyloyl pentapeptide‑33, and no peer‑reviewed reproductive toxicity data located. As a large peptide conjugate with no specific evidence of systemic reproductive toxicity, default hazard/mechanism scores are 0. The salicyloyl moiety raises a theoretical consideration (salicylates can have systemic effects at high exposure), but no data indicate that topical use of this peptide leads to relevant maternal exposure (sources checked: ECHA Annex VI, SCCS/CIR repositories, PubMed, PubChem, CosIng, EWG).
- salicyloyl pentapeptide-33 emzirirken güvenli mi?
- No data on transfer into breastmilk or lactation effects were found. Given the molecule class (peptidic cosmetic ingredient with likely low dermal absorption) and absence of reproductive/lactation signals in regulatory/search sources, hazard and mechanism scores default to 0 and exposure is judged negligible for typical topical cosmetic use.
- salicyloyl pentapeptide-33 bebek cildi için güvenli mi?
- No infant‑specific toxicity data found. Because the ingredient is not demonstrably non‑absorbable and infant skin has higher surface‑area‑to‑weight and immature barrier, exposure score is increased by +1 (adult e=0 → infant e=1). No evidence specific to developmental or dermatologic hazard in 0–3 yr olds was identified.
- VeriMom salicyloyl pentapeptide-33 nasıl puanlıyor?
- VeriMom salicyloyl pentapeptide-33'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte salicyloyl pentapeptide-33 yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.